Data & Drinks - Biotechs: Insights and Lessons Learned

​Hear from local start ups and lessons learned - such as: 

​- What are the challenges in today's research environment?
- How can I put myself in the best place for future funding?
- Is AI helping and how?

​​Please join us for Collaborative Drug Discovery's (CDD) Data & Drinks on April 16th 2026 at Princeton Innovation Center BioLabs while we enjoy an evening of drinks, hors d'oeuvres, and an exciting discussion on the topics above by our esteemed panelists.  

​​What to Expect

• ​​Networking & Drinks 
  Connect with industry peers, trade lessons learned, and explore collaborations over libations and appetizers. 

• ​​45-minute Actionable Panel Discussion with Experts 

  • ​​Romyr Dominique will be joined by 3 key leaders in the space: 

    • ​​Andy Cole - VP Chemistry at Arbutus Biopharma

    • ​Melissa Dumble - VP Pharmacology - at Eikon Therapeutics

    • ​Sandip Patel - Founder and CEO - Bioveric Pharmaceuticals

​​Sponsors 

​​Collaborative Drug Discovery (CDD) offers CDD Vault, a comprehensive, web-based informatics platform for managing and analyzing chemical and biological data.  Designed to facilitate secure collaboration among researchers globally, CDD Vault supports the entire drug discovery process, enabling efficient data capture, analysis, and sharing.  The CDD Vault helps streamline research efforts, optimize decision-making, and accelerate the path from discovery to development in the pharmaceutical and biotech industries. 

​​Reach out to Jacqueline Macia to learn more 

​​​Princeton Innovation Center BioLabs whose mission is to foster innovation, collaboration and entrepreneurship—in essence, to create and grow an innovation ecosystem—by supporting early-stage startups with high potential. Our mission is aligned with, and intended to further, Princeton University’s educational mission and the societal benefits of commercializing transformative technology.

​We understand the key challenges and pain-points science startups face. Our goal is to change how you do business by building an ecosystem that empowers entrepreneurial scientists to grow quickly, while maximizing capital efficiency.

​​Reach out to Michelle Roemer Schoen to learn more